
The pharmaceutical industry is well-positioned for significant expansion, driven by robust demand amid the growing prevalence of chronic diseases and an aging population, continued innovations and discoveries in drug discovery and development, and technological advances such as AI, big data analytics, and precision medicine.
Amid this backdrop, investors could consider investing in innovative pharmaceutical stocks Eli Lilly and Company (LLY), Bristol-Myers Squibb Company (BMY), and Merck & Co., Inc. (MRK) with game-changing treatments.